Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women
Abstract Background Eicosapentaenoic acid (EPA) and α-lipoic acid (α-LA) have been investigated for their beneficial effects on obesity and cardiovascular risk factors. In the current research, the goal was to evaluate metabolomic changes following the dietary supplementation of these two lipids, al...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-018-0750-4 |
id |
doaj-fe4571c6b14c4f43abf2673b977e3d19 |
---|---|
record_format |
Article |
spelling |
doaj-fe4571c6b14c4f43abf2673b977e3d192020-11-24T21:02:16ZengBMCLipids in Health and Disease1476-511X2018-05-0117111310.1186/s12944-018-0750-4Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese womenAna Romo-Hualde0Ana E. Huerta1Carlos J. González-Navarro2Omar Ramos-López3María J. Moreno-Aliaga4J. Alfredo Martínez5Centre for Nutrition Research, University of NavarraCentre for Nutrition Research, University of NavarraCentre for Nutrition Research, University of NavarraCentre for Nutrition Research, University of NavarraCentre for Nutrition Research, University of NavarraCentre for Nutrition Research, University of NavarraAbstract Background Eicosapentaenoic acid (EPA) and α-lipoic acid (α-LA) have been investigated for their beneficial effects on obesity and cardiovascular risk factors. In the current research, the goal was to evaluate metabolomic changes following the dietary supplementation of these two lipids, alone or combined in healthy overweight/obese sedentary women following an energy-restricted diet. For this purpose, an untargeted metabolomics approach was conducted on urine samples using liquid chromatography coupled with time of flight mass spectrometry (HPLC-TOF-MS). Methods This is a short-term double blind placebo-controlled study with a parallel nutritional design that lasted 10 weeks. Participants were assigned to one of the 4 experimental groups [Control, EPA (1.3 g/d), α-LA (0.3 g/d) and EPA+α-LA (1.3 g/d + 0.3 g/d)]. All intervention groups followed an energy-restricted diet of 30% less than total energy expenditure. Clinically relevant biochemical measurements were analyzed. Urine samples (24 h) were collected at baseline and after 10 weeks. Untargeted metabolomic analysis on urine samples was carried out, and principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were performed for the pattern recognition and characteristic metabolites identification. Results Urine samples were scattered in the PCA scores plots in response to the supplementation with α-LA. Totally, 28 putative discriminant metabolites in positive ionization, and 6 in negative ionization were identified among groups clearly differentiated according to the α-LA administration. Remarkably is the presence of an ascorbate intermediate metabolite (one of the isomers of trihydroxy-dioxohexanoate, or dihydroxy–oxohexanedionate) in the groups supplemented with α-LA. This fact might be associated with antioxidant properties of both α-LA and ascorbic acid. Correlations between phenotypical parameters and putative metabolites of provided additional information on whether there is a direct or inverse relationship between them. Especially interesting are the negative correlation between ascorbate intermediate metabolite and asymmetric dimethylarginine (ADMA) and the positive one between superoxide dismutase (SOD) and α-LA supplementation. Conclusions This metabolomic approach supports that the beneficial effects of α-LA administration on body weight reduction may be partly explained by the antioxidant properties of this organosulfur carboxylic acid mediated by isomers of trihydroxy-dioxohexanoate, or dihydroxy–oxohexanedionate. Trial registration Clinicaltrials.gov NCT01138774.http://link.springer.com/article/10.1186/s12944-018-0750-4α-lipoic acidEicosapentaenoic acidObesityOverweightMetabolomic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ana Romo-Hualde Ana E. Huerta Carlos J. González-Navarro Omar Ramos-López María J. Moreno-Aliaga J. Alfredo Martínez |
spellingShingle |
Ana Romo-Hualde Ana E. Huerta Carlos J. González-Navarro Omar Ramos-López María J. Moreno-Aliaga J. Alfredo Martínez Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women Lipids in Health and Disease α-lipoic acid Eicosapentaenoic acid Obesity Overweight Metabolomic |
author_facet |
Ana Romo-Hualde Ana E. Huerta Carlos J. González-Navarro Omar Ramos-López María J. Moreno-Aliaga J. Alfredo Martínez |
author_sort |
Ana Romo-Hualde |
title |
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women |
title_short |
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women |
title_full |
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women |
title_fullStr |
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women |
title_full_unstemmed |
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women |
title_sort |
untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women |
publisher |
BMC |
series |
Lipids in Health and Disease |
issn |
1476-511X |
publishDate |
2018-05-01 |
description |
Abstract Background Eicosapentaenoic acid (EPA) and α-lipoic acid (α-LA) have been investigated for their beneficial effects on obesity and cardiovascular risk factors. In the current research, the goal was to evaluate metabolomic changes following the dietary supplementation of these two lipids, alone or combined in healthy overweight/obese sedentary women following an energy-restricted diet. For this purpose, an untargeted metabolomics approach was conducted on urine samples using liquid chromatography coupled with time of flight mass spectrometry (HPLC-TOF-MS). Methods This is a short-term double blind placebo-controlled study with a parallel nutritional design that lasted 10 weeks. Participants were assigned to one of the 4 experimental groups [Control, EPA (1.3 g/d), α-LA (0.3 g/d) and EPA+α-LA (1.3 g/d + 0.3 g/d)]. All intervention groups followed an energy-restricted diet of 30% less than total energy expenditure. Clinically relevant biochemical measurements were analyzed. Urine samples (24 h) were collected at baseline and after 10 weeks. Untargeted metabolomic analysis on urine samples was carried out, and principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were performed for the pattern recognition and characteristic metabolites identification. Results Urine samples were scattered in the PCA scores plots in response to the supplementation with α-LA. Totally, 28 putative discriminant metabolites in positive ionization, and 6 in negative ionization were identified among groups clearly differentiated according to the α-LA administration. Remarkably is the presence of an ascorbate intermediate metabolite (one of the isomers of trihydroxy-dioxohexanoate, or dihydroxy–oxohexanedionate) in the groups supplemented with α-LA. This fact might be associated with antioxidant properties of both α-LA and ascorbic acid. Correlations between phenotypical parameters and putative metabolites of provided additional information on whether there is a direct or inverse relationship between them. Especially interesting are the negative correlation between ascorbate intermediate metabolite and asymmetric dimethylarginine (ADMA) and the positive one between superoxide dismutase (SOD) and α-LA supplementation. Conclusions This metabolomic approach supports that the beneficial effects of α-LA administration on body weight reduction may be partly explained by the antioxidant properties of this organosulfur carboxylic acid mediated by isomers of trihydroxy-dioxohexanoate, or dihydroxy–oxohexanedionate. Trial registration Clinicaltrials.gov NCT01138774. |
topic |
α-lipoic acid Eicosapentaenoic acid Obesity Overweight Metabolomic |
url |
http://link.springer.com/article/10.1186/s12944-018-0750-4 |
work_keys_str_mv |
AT anaromohualde untargetedmetabolomiconurinesamplesafteralipoicacidandoreicosapentaenoicacidsupplementationinhealthyoverweightobesewomen AT anaehuerta untargetedmetabolomiconurinesamplesafteralipoicacidandoreicosapentaenoicacidsupplementationinhealthyoverweightobesewomen AT carlosjgonzaleznavarro untargetedmetabolomiconurinesamplesafteralipoicacidandoreicosapentaenoicacidsupplementationinhealthyoverweightobesewomen AT omarramoslopez untargetedmetabolomiconurinesamplesafteralipoicacidandoreicosapentaenoicacidsupplementationinhealthyoverweightobesewomen AT mariajmorenoaliaga untargetedmetabolomiconurinesamplesafteralipoicacidandoreicosapentaenoicacidsupplementationinhealthyoverweightobesewomen AT jalfredomartinez untargetedmetabolomiconurinesamplesafteralipoicacidandoreicosapentaenoicacidsupplementationinhealthyoverweightobesewomen |
_version_ |
1716775964705292288 |